查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1433641

兽医原料药製造市场规模、份额、趋势分析报告：按动物类型、按服务类型、按合成类型、按治疗产品类别、按细分市场预测，2024-2030年

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, Share & Trends Analysis Report By Animal Type (Production, Companion), By Service Type, By Synthesis Type, By Therapeutic Category, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

兽药原料药製造市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球兽用原料药製造市场规模预计将达到134.7亿美元，2024年至2030年复合年增长率为6.8%。

推动市场成长的主要因素包括动物数量的增加和宠物的人性化、宠物的高支出、主要市场参与者的倡议、将製造功能外包给第三方、动物疾病的高流行等。例如，轩药业从事兽药生产，生产各种原料药，涵盖治疗类别、目标物种和合成类型。该公司生产两种专有 API：泰妙菌素和盐酸四环素。

将製造功能外包给第三方是市场成长的主要动力。这使得製药公司能够专注于研发、监管事务和行销等核心竞争力。对核心能力的策略关注提高了整体业务效率，并加速了新型兽用原料药的开发和商业化。透过外包给精通兽药的 CMO，製药公司可以利用经验丰富的专业人员的专业技能。拥有高效製造流程的 CMO 可以加快製造进度，使公司能够更快地将产品推向市场并快速回应新的市场需求。

监管机构和动物健康组织的倡议预计也将推动市场成长。例如，2023 年 9 月，美国FDA 宣布了一项促进动物生物技术和兽医创新的议程，作为动物和兽医创新议程的一部分。该议程旨在使 FDA 评估和支持创新兽药开发的方法现代化，并提高监管效率、弹性和可预测性。政府增加有助于改善动物健康的措施预计也将推动整体市场的成长。旨在加强动物保健标准的「同一个健康计画」的推出改善了该行业的成长前景。该合作计划将整合临床护理、疾病监测、教育和研究，以更好地控制该疾病。

兽药原料药製造市场报告亮点

  • 到 2023 年，化学原料药细分市场将以 71.3% 的份额占据市场主导地位。预计 2024 年至 2030 年，生物 API 领域将以 8.3% 的复合年增长率成长最快。
  • 2023 年，生产性动物部门占收益占有率最大。预计 2024 年至 2030 年，伴同性动物细分市场将以最快的速度成长。
  • 2023 年，内部部门的收益占有率最高。预计委託领域在预测期内将以最快的复合年增长率成长。
  • 2023年感染疾病品领域占比最高。其他治疗领域包括肿瘤学、糖尿病和其他药物。
  • 2023 年，北美地区市场领先，同年收益占有率最大，达 37.8%。同时，预计 2024 年至 2030 年亚太地区的复合年增长率将达到 7.9%，是最快的。
  • 由于动物疾病的高发生率以及人们对宠物保健的兴趣日益浓厚，对兽药的需求不断增长，这推动了对兽用原料药的需求。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章兽用 AP 製造市场：变数、趋势和范围

  • 市场体系展望
  • 市场动态
  • 兽药原料药製造市场分析工具
  • 2023 年以主要物种和主要国家估计的动物数量
  • COVID-19 影响分析

第 4 章 兽用 AP 製造市场：服务类型估计与趋势分析

  • 细分仪表板
  • 兽医 API 製造市场：2023 年和 2030 年服务类型变化分析
  • 在内部
  • 委託

第五章 兽用 AP 製造市场：合成类型的估算与估算/趋势分析

  • 细分仪表板
  • 兽用 AP 製造市场：2023 年和 2030 年合成类型变化分析
  • 基于化学的API
  • 生物原料药
  • HP API

第六章兽用 AP 製造市场：动物类型估计和趋势分析

  • 细分仪表板
  • 兽药 API 製造市场：动物类型变化分析，2023 年和 2030 年
  • 生产动物
  • 伴同性动物

第七章兽药原料药製造市场：治疗药物类别估算及趋势分析

  • 细分仪表板
  • 兽药原料药製造市场：2023年及2030年治疗药物类别波动分析
  • 驱虫药
  • 感染疾病
  • NSAID
  • 其他的

第八章兽用原料药製造市场：区域估计与趋势分析

  • 2023 年和 2030 年按地区分類的兽用 AP 製造市场占有率
  • 区域展望
  • 北美洲
    • 2018 年至 2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 2018 年至 2030 年市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 丹麦
    • 挪威
  • 亚太地区
    • 2018-2030 年市场估计与预测
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 2018 年至 2030 年市场估计与预测
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 2018 年至 2030 年市场估计与预测
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 科威特

第9章 竞争形势

  • 市场参与企业分类
  • 企业市场分析/堆图分析
  • 公司简介
    • Zoetis
    • Alivira Animal Health Limited
    • Ofichem Group
    • Chempro Pharma Private Limited
    • Siflon Drugs
    • Qilu Animal Health Products Co., Ltd.
    • Vetpharma
    • SUANFARMA
    • MENADIONA
    • Excel Industries Ltd.
  • 策略规划
    • 併购
    • 伙伴关係与协作
    • 其他的
  • 其他主要市场参与者名单
Product Code: GVR-4-68039-328-0

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Growth & Trends:

The global veterinary active pharmaceutical ingredients manufacturing market size is expected to reach USD 13.47 billion by 2030, registering a CAGR of 6.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The key factors driving market growth include rising animal population & pet humanization, high pet expenditure, initiatives by key market players, outsourcing of manufacturing functions to third parties, and a high prevalence of diseases in animals. Suanfarma, for instance, is involved in the veterinary manufacturing of a wide range of APIs across therapeutic categories, target species, and synthesis types. The company manufactures two proprietary APIs, namely, Tiamulin and Tetracycline HCl.

Outsourcing the manufacturing function to third parties is a significant driver of the market growth. This enables pharmaceutical companies to concentrate on their core competencies, such as R&D, regulatory affairs, and marketing. This strategic focus on core functions enhances overall operational efficiency and accelerates the development and commercialization of new veterinary APIs.Outsourcing to CMOs with expertise in animal health allows pharmaceutical companies to tap into the specialized skills of experienced professionals. This can improve product quality, compliance with regulatory standards, and enhanced manufacturing processes.Contract manufacturers with efficient processes can expedite the production timeline, allowing companies to launch their products more quickly and respond promptly to emerging market needs.

Initiatives by regulatory agencies and animal health organizations are also expected to drive market growth. For instance, in September 2023, the U.S. FDA released an agenda to promote innovation in animal biotech and veterinary products as part of the Animal and Veterinary Innovation Agenda. Thesesteps are intended to modernize the agency's approach to evaluating and supporting the development of innovative veterinary products thereby increasing regulatory efficiency, flexibility, and predictability. An increase in the number of government initiatives, that help promote animal health, is also expected to fuel the overall market growth. The launch of One Health Initiative for enhancing animal healthcare standards has improved growth prospects for the industry. This joint project unified clinical care, disease surveillance, and education & research areas for better control of diseases.

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report Highlights:

  • The chemical-based API segment dominated the market with a share of 71.3% in 2023. The biological API segment is anticipated to grow at the fastest CAGR of 8.3% from 2024 to 2030
  • The production animals segment held the largest revenue share in 2023. The companion animals segment is projected to grow at the fastest growth rate from 2024 to 2030
  • The in-house service type segment accounted for the highest revenue share in 2023. The contract outsourcing segment is projected to grow the fastest CAGR over the forecast years
  • The anti-infectives segment held the highest share in 2023. The other therapeutic category segment includes oncology, diabetes, and other drugs
  • North America was the leading regional market in 2023 and held the largest revenue share of 37.8% in the same year. Asia Pacific, on the other hand, is anticipated to register the fastest CAGR of 7.9% from 2024 to 2030
  • The growing need for veterinary drugs & pharmaceuticals due to the high prevalence of animal diseases and an increasing focus on pet healthcare drive the demand for veterinary APIs

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
    • 1.7.2. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Increasing uptake of CDMO services
      • 3.2.1.2. Increasing advancements in veterinary medicine
      • 3.2.1.3. Increasing prevalence of diseases in animals
      • 3.2.1.4. Increasing animal health expenditure
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Complex regulations
      • 3.2.2.2. Limited Awareness and Education
  • 3.3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape
  • 3.4. Estimated Animal Population, by Key Species & Key Countries, 2023
  • 3.5. COVID-19 Impact Analysis

Chapter 4. Veterinary Active Pharmaceutical Ingredients Manufacturing Market: Service Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Veterinary active pharmaceutical ingredients manufacturing market: service type movement analysis, 2023 & 2030 (USD Million)
  • 4.3. In House
    • 4.3.1. In house market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4. Contract Outsourcing
    • 4.4.1. Contract outsourcing market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Contract Development
      • 4.4.2.1. Contract development market revenue estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.2. Preclinical Development
      • 4.4.2.2.1. Preclinical development market revenue estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.3. Clinical Development
      • 4.4.2.3.1. Clinical development market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Contract Manufacturing
      • 4.4.3.1. Contract manufacturing market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market: Synthesis Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Veterinary active pharmaceutical ingredients manufacturing market: synthesis type movement analysis, 2023 & 2030 (USD Million)
  • 5.3. Chemical-based API
    • 5.3.1. Chemical-based API market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4. Biological API
    • 5.4.1. Biological API market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. HPAPI
    • 5.5.1. HPAPI market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market: Animal Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Veterinary active pharmaceutical ingredients manufacturing market: animal type movement analysis, 2023 & 2030 (USD Million)
  • 6.3. Production Animals
    • 6.3.1. Production animals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.4. Companion Animals
    • 6.4.1. Companion animals market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market: Therapeutic Category Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Veterinary active pharmaceutical ingredients manufacturing market: therapeutic category movement analysis, 2023 & 2030 (USD Million)
  • 7.3. Antiparasitics
    • 7.3.1. Antiparasitics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4. Anti-infectives
    • 7.4.1. Anti-infectives market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5. NSAIDs
    • 7.5.1. NSAIDs market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market: Regional Estimates & Trend Analysis

  • 8.1. Veterinary active pharmaceutical ingredients manufacturing market share, by region, 2023 & 2030, (USD Million)
  • 8.2. Regional Outlook
  • 8.3. North America
    • 8.3.1. North America veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. U.S. veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Canada veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. UK veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Germany veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. France veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Italy veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Spain veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Sweden veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Denmark veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Norway veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. China veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Japan
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Japan veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. India veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. South Korea veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Australia veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Thailand veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Brazil veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Mexico
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Mexico veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. Argentina
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Argentina veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.7. Middle East and Africa
    • 8.7.1. Middle East and Africa veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. UAE veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.7.4. South Africa
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. South Africa veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Kuwait veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Company Market Position Analysis/ Heap Map Analysis
  • 9.3. Company Profiles
    • 9.3.1. Zoetis
      • 9.3.1.1. Participant's Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Alivira Animal Health Limited
      • 9.3.2.1. Participant's Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Ofichem Group
      • 9.3.3.1. Participant's Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Chempro Pharma Private Limited
      • 9.3.4.1. Participant's Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Siflon Drugs
      • 9.3.5.1. Participant's Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Qilu Animal Health Products Co., Ltd.
      • 9.3.6.1. Participant's Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Vetpharma
      • 9.3.7.1. Participant's Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. SUANFARMA
      • 9.3.8.1. Participant's Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Product Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. MENADIONA
      • 9.3.9.1. Participant's Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Product Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Excel Industries Ltd.
      • 9.3.10.1. Participant's Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Product Benchmarking
      • 9.3.10.4. Strategic Initiatives
  • 9.4. Strategy Mapping
    • 9.4.1. Mergers & Acquisitions
    • 9.4.2. Partnerships & Collaborations
    • 9.4.3. Others
  • 9.5. List of Other Key Market Players

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Global veterinary active pharmaceutical ingredients manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 4 Global veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 -2030 (USD Million)
  • Table 5 Global veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 6 Global veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 7 Global veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 8 Global veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 9 North America veterinary active pharmaceutical ingredients manufacturing market, by country, (USD Million) 2018 - 2030 (USD Million)
  • Table 10 North America veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 11 North America veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 12 North America veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 13 North America veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 14 North America veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 15 North America veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 16 U.S. veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 17 U.S. veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 18 U.S. veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 19 U.S. veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 20 U.S. veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 21 U.S. veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 22 Canada veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 23 Canada veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, (USD Million) 2018 - 2030 (USD Million)
  • Table 24 Canada veterinary active pharmaceutical ingredients manufacturing market, by service type, (USD Million) 2018 - 2030 (USD Million)
  • Table 25 Canada veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, (USD Million) 2018 - 2030 (USD Million)
  • Table 26 Canada veterinary active pharmaceutical ingredients manufacturing market, by contract development, (USD Million) 2018 - 2030 (USD Million)
  • Table 27 Canada veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, (USD Million) 2018-2030 (USD Million)
  • Table 28 Europe veterinary active pharmaceutical ingredients manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 29 Europe veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 30 Europe veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 31 Europe veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 32 Europe veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 33 Europe veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 34 Europe veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 35 Germany veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 36 Germany veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 37 Germany veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 38 Germany veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 39 Germany veterinary active pharmaceutical ingredients manufacturing , by contract development, 2018 - 2030 (USD Million)
  • Table 40 Germany veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 41 UK veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 42 UK veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, (USD Million) 2018- 2030 (USD Million)
  • Table 43 UK veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
  • Table 44 UK veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
  • Table 45 UK veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
  • Table 46 UK veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 47 France veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 48 France veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 49 France veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 50 France veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 51 France veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 52 France veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 53 Italy veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 54 Italy veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 55 Italy veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 56 Italy veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 57 Italy veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 58 Italy veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 59 Spain veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 60 Spain veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 61 Spain veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 62 Spain veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 63 Spain veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 64 Spain veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 65 Denmark veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 66 Denmark veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 67 Denmark veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 68 Denmark veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 69 Denmark veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 70 Denmark veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 71 Sweden veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 72 Sweden veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 73 Sweden veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 74 Sweden veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 75 Sweden veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 76 Sweden veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 77 Norway veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 78 Norway veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 79 Norway veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 80 Norway veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 81 Norway veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 82 Norway veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 83 Asia Pacific veterinary active pharmaceutical ingredients manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 84 Asia Pacific veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 85 Asia Pacific veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 86 Asia Pacific veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 87 Asia Pacific veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 88 Asia Pacific veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 89 Asia Pacific veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 90 China veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 91 China veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 92 China veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 93 China veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 94 China veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 95 China veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 96 Japan veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 97 Japan veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 98 Japan veterinary active pharmaceutical ingredients manufacturing market, by service type, (USD Million) 2018-2030 (USD Million)
  • Table 99 Japan veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 100 Japan veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 101 Japan veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 102 India veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 103 India veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 104 India veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 105 India veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 106 India veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 107 India veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 108 South Korea veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 109 South Korea veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 110 South Korea veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 111 South Korea veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 112 South Korea veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 113 South Korea veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 114 Australia veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 115 Australia veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 116 Australia veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 117 Australia veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 118 Australia veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 119 Australia veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 120 Thailand veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 121 Thailand veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 122 Thailand veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 123 Thailand veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 124 Thailand veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 125 Thailand veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 126 Latin America veterinary active pharmaceutical ingredients manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 127 Latin America veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 128 Latin America veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 129 Latin America veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 130 Latin America veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 131 Latin America veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 132 Latin America veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 133 Brazil veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 134 Brazil veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 135 Brazil veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 136 Brazil veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 137 Brazil veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 138 Brazil veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 139 Mexico veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 140 Mexico veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 141 Mexico veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 142 Mexico veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 143 Mexico veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 144 Mexico veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 145 Argentina veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 146 Argentina veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 147 Argentina veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 148 Argentina veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 149 Argentina veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 150 Argentina veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 151 MEA veterinary active pharmaceutical ingredients manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 152 MEA veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 153 MEA veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 154 MEA veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 155 MEA veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 156 MEA veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 157 MEA veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 158 South Africa veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 159 South Africa Veterinary Active Pharmaceutical Ingredients Manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 160 South Africa veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 161 South Africa veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 162 South Africa veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 163 South Africa veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 164 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 165 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 166 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 167 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 168 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 169 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, (USD Million) 2018 - 2030 (USD Million)
  • Table 170 UAE veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 171 UAE veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 172 UAE veterinary active pharmaceutical ingredients manufacturing market, by service type, (USD Million) 2018-2030 (USD Million)
  • Table 173 UAE veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 174 UAE veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 175 UAE veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 176 Kuwait veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 177 Kuwait veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 178 Kuwait veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 179 Kuwait veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 180 Kuwait veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 181 Kuwait veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 182 Company Overview
  • Table 183 Product Benchmarking
  • Table 184 Financial Performance
  • Table 185 Strategic Initiatives

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Commodity Flow Analysis
  • Fig. 9 Veterinary active pharmaceutical ingredients manufacturing market outlook
  • Fig. 10 Veterinary active pharmaceutical ingredients manufacturing market snapshot
  • Fig. 11 Veterinary active pharmaceutical Ingredients Manufacturing market driver impact
  • Fig. 12 Veterinary active pharmaceutical ingredients manufacturing market restraint impact
  • Fig. 13 Porter's 5 Forces Analysis
  • Fig. 14 PESTEL Analysis
  • Fig. 15 Veterinary active pharmaceutical ingredients manufacturing market animal type key takeaways (USD Million)
  • Fig. 16 Veterinary active pharmaceutical ingredients manufacturing market: animal type movement & market share analysis, 2023 & 2030
  • Fig. 17 Global production animals market, 2018 - 2030 (USD Million)
  • Fig. 18 Global companion animals market, 2018 - 2030 (USD Million)
  • Fig. 19 Veterinary active pharmaceutical ingredients manufacturing market: Synthesis Type and key takeaways (USD Million)
  • Fig. 20 Veterinary active pharmaceutical ingredients manufacturing market: synthesis type movement & market share analysis, 2023 & 2030
  • Fig. 21 Global chemical based API market, 2018 - 2030 (USD Million)
  • Fig. 22 Global biological API market, 2018 - 2030 (USD Million)
  • Fig. 23 Global HPAPI market, 2018 - 2030 (USD Million)
  • Fig. 24 Veterinary active pharmaceutical ingredients manufacturing market: Service type & key takeaways (USD Million)
  • Fig. 25 Veterinary active pharmaceutical ingredients manufacturing market: Service type movement & market share analysis, 2023 & 2030
  • Fig. 26 Global in house market, 2018 - 2030 (USD Million)
  • Fig. 27 Global contract outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 28 Global contract development market, 2018 - 2030 (USD Million)
  • Fig. 29 Global contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 30 Global preclinical development market, 2018 - 2030 (USD Million)
  • Fig. 31 Global clinical development market, 2018 - 2030 (USD Million)
  • Fig. 32 Veterinary active pharmaceutical ingredients manufacturing market: Therapeutic category & key takeaways (USD Million)
  • Fig. 33 Veterinary active pharmaceutical ingredients manufacturing market: Therapeutic Category movement & market share analysis, 2023 & 2030
  • Fig. 34 Global antiparasitics market, 2018 - 2030 (USD Million)
  • Fig. 35 Global Anti-infectives market, 2018 - 2030 (USD Million)
  • Fig. 36 Global NSAIDs market, 2018 - 2030 (USD Million)
  • Fig. 37 Global Others market, 2018 - 2030 (USD Million)
  • Fig. 38 Regional market place: Key takeaways
  • Fig. 39 Regional outlook, 2023 & 2030
  • Fig. 40 North America veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 42 Canada veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 43 Europe veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 44 UK veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 45 Germany veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 46 France veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 47 Italy veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 48 Spain veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 51 Norway veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 54 China veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 55 India veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 56 South Korea veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 57 Australia veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 58 Thailand veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 59 Latin America veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 60 Brazil veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 61 Mexico veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 62 Argentina veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 63 MEA veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 64 South Africa veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 65 UAE veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 66 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 67 Kuwait veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 68 Market participant categorization
  • Fig. 69 Heat map analysis